Spectral expands sales of heart test:
This article was originally published in Clinica
Spectral Diagnostics has expanded the European sales of its STATus point-of-care heart attack tests following the signing of three distribution agreements. Medixon will sell the tests in Israel, where it is based, as well as in Cyprus and Jordan. Greece and Turkey will be handled by Median*s agent Gerolymatos. Intex will sell the kits in Hungary, while Slovakia and the Czech Republic are to be served by Aris Jicin. The two STATus tests detect troponin-I, and CK-MB and Myoglobin.